The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2


Gernot Polier,Jennifer Neumann,Frédéric Thuaud,Nigel Ribeiro,Christoph Gelhaus,Hendrik Schmidt,Marco Giaisi,Rebecca Köhler,Wolfgang W. Müller,Peter Proksch,Matthias Leippe,Ottmar Janssen,Laurent Désaubry,Peter H. Krammer,Min Li-Weber


Chemistry & Biology




21 September 2012

Copyright © 2012, Elsevier

 User ID  
 Enable Auto Login
Forgot Password/User ID?
If you're a copyright.com user, you can login to RightsLink using your copyright.com credentials.
Already a RightsLink user or want to learn more?

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.

I would like to...


To request permission for a type of use not listed, please contact Elsevier Global Rights Department.

Are you the author of this Elsevier journal article?


Copyright © 2014 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com